recombinant human insulin

DRUG3 trials

Sponsors

University of Versailles, Biodel, Instituto de Oftalmología Fundación Conde de Valenciana

Conditions

Diabetes Mellitus Type 1Dry EyeSeptic ShockSjogren Syndrome

Phase 1

Pharmacokinetic and Pharmacodynamic Properties of BIOD-105 and BIOD-107 Compared to Humalog® in Subjects With Type 1 Diabetes

CompletedNCT01334151

BiodelDiabetes Mellitus Type 1

Start: 2011-03-31End: 2011-08-31Updated: 2013-07-26

Phase 3

Combination of Corticotherapy and Intensive Insulin Therapy for Septic Shock

CompletedNCT00320099

University of VersaillesSeptic Shock

Start: 2006-01-31End: 2009-02-28Updated: 2010-04-06

Comparing Efficacy of Autologous Serum Eye Drops With and Without Insulin in Autoimmune Dry Eye.

CompletedNCT06931041

Instituto de Oftalmología Fundación Conde de ValencianaDry Eye, Sjogren Syndrome

Start: 2024-02-01End: 2025-06-01Updated: 2026-08-27

Related Papers

Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial.

2010-01-01213 citations